INDIVIOR EU LIMITED

Company Information

Company Number
08122832
Registered Address
234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Status
Active
Employee Count
4
Turnover
Coming Soon
EBITDA
-£37,000

Additional Details

Company Type
Private limited Company
Incorporated On
28 June 2012
Nature of Business
21100 - Manufacture of basic pharmaceutical products
Industries
Life Sciences And Medical Technology
Region
South East

Time to Pay

Average Time to Pay
138 days
Shortest Period:0 days
Longest Period:120 days
Max Contractual:120 days

Payment Timeline

Within 30 Days
31%
31-60 Days
14%
After 60 Days
55%
Not Paid Within Terms85%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Performance Reports History

Reporting Period Filed: 2019-07-29
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jan 2019 - 30 Jun 201929 Jul 201913831%14%55%85%
01 Jul 2018 - 31 Dec 201821 Jan 20195248%30%22%75%
01 Jan 2018 - 30 Jun 201826 Jul 20185248%30%22%75%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

30 days from date of invoice

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

Payment terms are agreed up front with the supplier as part of the purchasing negotiations

Maximum contractual payment period agreed

120

Dispute Resolution Process

All our suppliers have the possibility to resolve disputes via our Accounts payable team, or escalating to our Procurement Team if not satisfied

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

INDIVIOR EU LIMITED is a pharmaceutical company based in the United Kingdom that specializes in the development and distribution of products and services for the treatment of addiction and related mental health disorders.

Their main focus is on providing innovative solutions for opioid dependence, including medication-assisted treatment and behavioral therapy. This is in line with their goal to improve the quality of life for individuals struggling with addiction and to reduce the societal and economic burden of substance abuse.

In addition to their products and services, INDIVIOR EU LIMITED also has a strong commitment to sustainability. They have implemented various initiatives to reduce their environmental impact, such as reducing waste and energy consumption in their operations.

The key people at INDIVIOR EU LIMITED include the CEO, Shaun Thaxter, and the Chairman of the Board, Howard Pien. They are supported by a team of experienced professionals in the fields of pharmaceuticals, healthcare, and business.

For further information on INDIVIOR EU LIMITED and their products and services, their website address is www.indivior.com. Their registered office address is 103-105 Bath Road, Slough, Berkshire, SL1 3UH, United Kingdom.

In summary, INDIVIOR EU LIMITED is a leading pharmaceutical company in the UK, with a focus on providing innovative solutions for opioid dependence and a strong commitment to sustainability. Their team of experienced professionals and their dedication to improving the lives of individuals struggling with addiction make them a trusted and reputable company in the healthcare industry.

Financial Metrics

Cash
£25,097
Net Worth
£21,549,978
Total Current Assets
£24,218,952
Total Current Liabilities
£2,668,974

Company Location